EGFR is overexpressed in approximately 90% of HNSCC cases, and its aberrant activation in laryngeal carcinoma promotes uncontrolled proliferation, radiotherapy resistance, and poor prognosis (112, 113). This evidence concerns the gene EGFR and laryngeal carcinoma.